fda warning bpc-157 safety not approved bpc 157 BPC-157: What you need to know before you An FDA Committee Just Voted

(2017) in a rat TBI model suggested BPC-157 could reduce neuronal damage and improve functional outcomes

This article is for educational purposes only and is not medical advice

At present: There is no FDA approval There is no standard prescription pathway There is no approved supplement classification There is no lawful retail medical distribution model The only compliant framework that exists today is legitimate research distribution , meaning: Supplied for scientific investigation Not sold as treatment Not administered to patients Not marketed for healing or recovery Anything else blurs into non-compliance

Patients who were not prepared for this tend to question whether the peptide is working